Genetic heterogeneity among fanconi anemia heterozygotes and risk of cancer

Cancer Research

Volumn 67, Issue 19, 2007, Pages 9591-9596

  Berwick, Marianne ^a   Satagopan, Jaya M ^b   Ben Porat, Leah ^b   Carlson, Ann ^b   Mah, Katherine ^b   Henry, Rashida ^b   Diotti, Raffaella ^b   Milton, Kelly ^b   Pujara, Kanan ^b   Landers, Tom ^b   Batish, Sat Dev ^b   Morales, José ^b   Schindler, Detlev ^c   Hanenberg, Helmut ^d   Hromas, Robert ^a   Levran, Orna ^b   Auerbach, Arleen D ^b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; DNA DETERMINATION; FAMILY HISTORY; FANCONI ANEMIA; FEMALE; GENETIC HETEROGENEITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; REGISTRATION; STATISTICAL ANALYSIS;

BREAST NEOPLASMS; FANCONI ANEMIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MALE; NEOPLASMS;

EID: 35148853561     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-1501     Document Type: Article

References (34)

1. Alter BP. Cancer in Fanconi anemia, 1927-2001. Cancer 2003;97:425-40.
2. Kutler DL, Singh B, Satagopan J, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 2003;101:1249-56.
3. Taniguchi T, D'Andrea AD. Molecular pathogenesis of Fanconi anemia: recent progress. Blood 2006;107:4223-33.
4. Taniguchi T, Tischkowitz M, Ameziane N, et al. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med 2003;9:568-74.
5. Surralles J, Jackson SP, Jasin M, Kastan MB, West SC, Joenje H. Molecular cross-talk among chromosome fragility syndromes. Genes Dev 2004;18:1359-70.
6. Bagby GC, Alter BP. Fanconi anemia. Semin Hematol 2006;43:147-56.
7. Garriga S, Crosby WH. The incidence of leukemia in families of patients with hypoplasia of the marrow. Blood 1959;14:1008-14.
8. Swift M. Fanconi's anaemia in the genetics of neoplasia. Nature 1971;230:370-3.
9. Potter NU, Sarmousakis D, Li FP. Cancer in relatives of patients with aplastic anemia. Cancer Genet Cytogenet 1983;9:61-5.
10. Awan A, Malcolm Taylor G, Gokhale DA, et al. Increased frequency of Fanconi anemia group C genetic variants in children with sporadic acute myeloid leukemia. Blood 1998;91:4813-4.
11. Seal S, Barfoot R, Jayatilake H, et al. Evaluation of Fanconi anemia genes in familial breast cancer predisposition. Cancer Res 2003;63:8596-9.
12. Seal S, Thompson D, Renwick A, et al. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 2006;38:1239-41.
13. Hodgson SV, Morrison PJ, Irving M. Breast cancer genetics: unsolved questions and open perspectives in an expanding clinical practice. Am J Med Genet C Semin Med Genet 2004;129:56-64.
14. Barroso E, Milne RL, Fernandez LP, et al. FANCD2 associated with sporadic breast cancer risk. Carcinogenesis 2006;27:1930-7.
15. Rahman N, Seal S, Thompson D, et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 2007;39:165-7.
16. Mathew CG. Fanconi anaemia genes and susceptibility to cancer. Oncogene 2006;25:5875-85.
17. Auerbach AD. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol 1993;21:731-3.
18. Hanenberg H, Batish SD, Pollock KE, et al. Phenotypic correction of primary Fanconi anemia T cells from patients with retroviral vectors as a diagnostic tool. Exp Hematol 2002;30:410-20.
19. Garcia-Higuera I, Taniguchi T, Ganesan S, et al. Interaction of the Fanconi proteins and BRCA1 in a common pathway. Mol Cell 2001;7:249-62.
20. Morgan NV, Tipping AJ, Joenje H, Mathew CG. High frequency of large intragenic deletions in the Fanconi anemia group A gene. Am J Hum Genet 1999;65:1330-41.
21. Callen E, Tischkowitz MD, Creus A, et al. Quantitative PCR analysis reveals a high incidence of large intragenic deletions in the FANCA gene in Spanish Fanconi anemia patients. Cytogenet Genome Res 2004;104:341-5.
22. Schouten JP, McElgunn CJ, Waaijer R, Zwijneburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation dependent probe amplification. Nucleic Acids Res 2002;30:e57.
23. Levran O, Diotti R, Pujara K, Batish SD, Hanenberg H, Auerbach AD. Spectrum of sequence variations in the FANCA gene: an International Fanconi Anemia Registry (IFAR) study. Hum Mutat 2005;25:142-9.
24. Breslow NE, Day NE. statistical methods in cancer research. Vol. 2. Lyon: IARC; 1987.
25. Hunter DJ, Kraft P, Jacobs KB, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007;39:870-4.
26. Gillio AP, Verlander PC, Batsh SD, Giampietro PF, Auerbach AD. Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study. Blood 1997;90:105-10.
27. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 2000;14:927-39.
28. Sims AE, Spiteri E, Sims RJ, et al. FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. Nat Struct Mol Biol 2007;14:564-7.
29. Smogorzewska A, Matsuoka S, Vinciguerra P, et al. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 2007;129:289-301.
30. Kitao H, Yamamoto K, Matsushita N, Ohzeki M, Ishiai M, Takata M. Functional interplay between BRCA2/FancD1 and FancC in DNA repair. J Biol Chem 2006;281:21312-20.
31. Pang Q, Christianson TA, Keeble W, et al. The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality. Blood 2001;98:1392-401.
32. Bergmann MM, Byers T, Freedman DS, Mokdad A. Validity of self-reported diagnoses leading to hospitalization: a comparison of self-reports with hospital records in a prospective study of American adults. Am J Epidemiol 1998;147:969-77.
33. Parikh-Patel A, Allen M, Wright WE; California Teachers Study Steering Committee. Validation of self-reported cancers in the California Teachers Study. Am J Epidemiol 2003;157:539-45.
34. Verlander PC, Kaporis A, Liu Q, Zhang Q, Seligsohn U, Auerbach AD. Carrier frequency of the IVS4+4A>T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population. Blood 1995;86:4034-8.